Nyvepria
Active Ingredient(s): Pegfilgrastim-apgfFDA Approved: * June 10, 2020
Pharm Company: * HOSPIRA INC
Category: Cancer
Pegfilgrastim, sold under the brand name Neulasta among others, is a PEGylated form of the recombinant human granulocyte colony-stimulating factor (GCSF) analog filgrastim.[5] It serves to stimulate the production of white blood cells (neutrophils).[5][7] Pegfilgrastim was developed by Amgen.[8] Pegfilgrastim treatment can be used to stimulate bone marrow to produce more neutrophils to fight infection in patients undergoing chemo... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.Dosage List
Nyvepria 6 mg/.6ml Subcutaneous Injection, Solution
NDC: 0069-0324
Labeler:
Pfizer Laboratories Div Pfizer Inc
